Search Results 1561-1570 of 19436 for hemoglobin

  1. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

    Hemoglobin > 8 g/dL;; Resolved acute effects of any prior therapy to baseline severity or Common Terminology Criteria for Adverse Events (CTCAE) Grade < 1 ...

  2. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    * Hemoglobin levels \< 8.0 g/dL (\< 5 mmol/L), or \< 7.0 g/dL (\< 4.3 mmol/L) if related to participant's SLE such as in active hemolytic anaemia * Platelet ...

  3. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    Adequate hematological function (neutrophils >1 × 109/L, platelet count >100 × 109/L, hemoglobin >9 g/dL) with no prior transfusions within 2 weeks.

  4. Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis - Mayo Clinic

    Hemoglobin < 9.0 mg/dl, INR > 1.6 before warfarin was started, or platelets < 100,000/ml. Moderate renal impairment in diabetic patients (estimated GFR < 60 ...

  5. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

    Hemoglobin < 9 g/dL in males and < 8 g/dL in females;; Neutrophils < 1.0 × 10^9/L;; Platelets < 75 × 10^9/L;; Creatinine clearance < 50 mL/min on screening ...

  6. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU - Mayo Clinic

    Patients must have adequate organ and marrow function as defined by the following laboratory values obtained ≤14 days prior to registration: Hemoglobin > 9.0 g ...

  7. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  8. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM) - Mayo Clinic

    Hemoglobin > 8 g/dL;; Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) < 20 times the upper limit of the institutional normal ranges. Women ...

  10. Study Of Carboplatin And Mirvetuximab Soravtansine In First-Line Treatment Of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube Or Primary Peritoneal Cancer - Mayo Clinic

    * Hemoglobin ≥ 9.0 g/dL * Serum creatinine ≤ 1.5 x upper limit of normal (ULN) * Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ...